Deerfield Management Company, L.P. 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Deerfield Management Company, L.P. disclosed 105 US equity positions worth $5.3bn in its Q4 2024 13F filing. The largest position was NUVALENT INC at 26.8% of the reported book, followed by VTRS and INTEGRA LIFESCIENCES HLDGS C. Against the Q3 2024 filing, it opened 2 new positions, added to 13 and reduced 14 among the top 50 holdings.
What did Deerfield Management Company, L.P. own in Q4 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | NUVALENT INC | 26.8% | $1.4bn | 17,991,024 | -10% | reduced | |
| 2 | VTRS VIATRIS INC | Healthcare | 5.7% | $298.8m | 23,996,036 | 0% | held |
| 3 | INTEGRA LIFESCIENCES HLDGS C | 3.2% | $168.2m | 174,364,000 | 0% | held | |
| 4 | CNC CENTENE CORP DEL | Healthcare | 3.1% | $161.9m | 2,671,921 | 1% | added |
| 5 | OSCR OSCAR HEALTH INC | Healthcare | 3.0% | $159.1m | 11,835,000 | 51% | added |
| 6 | RVMD REVOLUTION MEDICINES INC | Healthcare | 2.7% | $142.5m | 3,258,332 | 12% | added |
| 7 | MERUS N V | 2.4% | $125.0m | 2,972,787 | -13% | reduced | |
| 8 | ACCOLADE INC | 2.4% | $124.5m | 132,598,000 | 0% | held | |
| 9 | WAY WAYSTAR HLDG CORP | Healthcare | 2.3% | $120.9m | 3,295,260 | -33% | reduced |
| 10 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 2.2% | $117.7m | 862,000 | -35% | reduced |
| 11 | ALNY ALNYLAM PHARMACEUTICALS INC | 2.2% | $117.3m | 110,000,000 | 10% | added | |
| 12 | SPRY ARS PHARMACEUTICALS INC | Healthcare | 2.1% | $110.9m | 10,514,657 | -5% | reduced |
| 13 | NEWAMSTERDAM PHARMA COMPANY | 2.1% | $110.9m | 4,314,340 | 378% | added | |
| 14 | INDIVIOR PLC | 2.1% | $110.4m | 8,883,160 | 74% | added | |
| 15 | MIRM MIRUM PHARMACEUTICALS INC | 2.0% | $106.6m | 70,000,000 | 0% | held | |
| 16 | AHCO ADAPTHEALTH CORP | Healthcare | 1.8% | $92.5m | 9,711,410 | 0% | held |
| 17 | ALHC ALIGNMENT HEALTHCARE INC | Healthcare | 1.6% | $82.2m | 7,304,302 | -33% | reduced |
| 18 | LRMR LARIMAR THERAPEUTICS INC | Healthcare | 1.6% | $82.2m | 21,231,974 | 0% | held |
| 19 | BKD BROOKDALE SR LIVING INC | Healthcare | 1.5% | $78.5m | 15,612,264 | 0% | held |
| 20 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 1.3% | $70.3m | 2,736,000 | 5% | added |
| 21 | EMBC EMBECTA CORP | Healthcare | 1.3% | $67.5m | 3,270,535 | 20% | added |
| 22 | DVAX DYNAVAX TECHNOLOGIES CORP | 1.3% | $66.3m | 5,193,823 | 23990% | added | |
| 23 | CATALYST PHARMACEUTICALS INC | 1.2% | $65.4m | 3,133,011 | -50% | reduced | |
| 24 | ACH OWENS & MINOR INC NEW | Healthcare | 1.2% | $64.2m | 4,911,979 | 0% | held |
| 25 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 1.2% | $61.2m | 8,144,442 | 0% | held |
| 26 | BAX BAXTER INTL INC | Healthcare | 1.1% | $56.1m | 1,923,100 | 0% | held |
| 27 | EWTX EDGEWISE THERAPEUTICS INC | 1.1% | $55.5m | 2,078,509 | 17% | added | |
| 28 | LEGN LEGEND BIOTECH CORP | Healthcare | 1.0% | $50.5m | 1,551,718 | – | new |
| 29 | BIO BIO RAD LABS INC | Healthcare | 0.9% | $49.8m | 151,644 | 0% | held |
| 30 | ALPHATEC HLDGS INC | 0.9% | $46.7m | 49,500,000 | -58% | reduced | |
| 31 | CNMD CONMED CORP | Healthcare | 0.8% | $41.9m | 611,964 | -0% | held |
| 32 | CGEM CULLINAN THERAPEUTICS INC | Healthcare | 0.8% | $41.2m | 3,379,399 | 3% | added |
| 33 | ENHABIT INC | 0.7% | $39.1m | 5,010,972 | 0% | held | |
| 34 | LKFT GALAPAGOS NV | Healthcare | 0.7% | $38.8m | 1,411,000 | 0% | held |
| 35 | PHVS PHARVARIS N V | 0.7% | $38.7m | 2,017,464 | -1% | reduced | |
| 36 | IRON DISC MEDICINE INC | Healthcare | 0.7% | $38.1m | 600,515 | -41% | reduced |
| 37 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 0.6% | $34.2m | 145,191 | 0% | held |
| 38 | LANTHEUS HLDGS INC | 0.6% | $33.7m | 25,255,000 | 0% | held | |
| 39 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 0.6% | $32.9m | 2,596,033 | -1% | reduced | |
| 40 | PHR PHREESIA INC | Healthcare | 0.6% | $32.0m | 1,271,832 | 134% | added |
| 41 | BCAX BICARA THERAPEUTICS INC | 0.6% | $31.3m | 1,795,174 | 0% | held | |
| 42 | DCGO DOCGO INC | 0.6% | $30.5m | 7,195,956 | -21% | reduced | |
| 43 | INMD INMODE LTD | Healthcare | 0.5% | $26.4m | 1,578,708 | 0% | held |
| 44 | SVRA SAVARA INC | Healthcare | 0.5% | $24.4m | 7,964,000 | 23% | added |
| 45 | CGON CG ONCOLOGY INC | Healthcare | 0.5% | $24.4m | 851,593 | 0% | held |
| 46 | KYMR KYMERA THERAPEUTICS INC | Healthcare | 0.5% | $23.9m | 593,000 | – | new |
| 47 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 0.4% | $23.5m | 6,710,429 | 0% | held |
| 48 | TXG 10X GENOMICS INC | Healthcare | 0.4% | $21.5m | 1,497,000 | -1% | reduced |
| 49 | LNTH LANTHEUS HLDGS INC | Healthcare | 0.4% | $21.5m | 240,218 | 0% | held |
| 50 | COGT COGENT BIOSCIENCES INC | Healthcare | 0.4% | $20.5m | 2,631,000 | -30% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.